| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000046579 |
| Receipt No. | R000053139 |
| Scientific Title | A evaluation study of the effect of test food on human sleep. -Open Study- |
| Date of disclosure of the study information | 2022/01/10 |
| Last modified on | 2022/03/30 (Ver. 2) |
| Basic information | ||
| Public title | A evaluation study of the effect of test food on human sleep.
-Open Study- |
|
| Acronym | A evaluation study of the effect of test food on human sleep. | |
| Scientific Title | A evaluation study of the effect of test food on human sleep.
-Open Study- |
|
| Scientific Title:Acronym | A evaluation study of the effect of test food on human sleep. | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adults | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To verify the effect of test food on human sleep. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | EEG during sleep (Sleep scope) |
| Key secondary outcomes | The Japanese version of the Pittsburgh Sleep Quality Index
OSA sleep inventory MA version Visual Analogue Scale |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Take test food once a day, 2 capsules, for 4 weeks. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Males and females from 30 to 59 years of age.
2. Subjects with a PSQI-J global score of 6 or higher at the time of screening test. 3. Subjects who can make self-judgment and are voluntarily giving written informed consent. |
|||
| Key exclusion criteria | 1. Subjects who are currently under treatment for sleep, stress and fatigue, and who are using medicines and health foods related to sleep, stress and fatigue.
2. Subjects who consistently drink more than the appropriate amount of alcohol (about 20 g of pure alcohol per day). 3. Subjects who aren't abele to stop eating foods and drinks high in caffeine from 15:00 to bedtime during this research period. 4. Subjects who are midnight-shift worker or shift worker. 5. Subjects who are suffering from, undergoing treatment for, or with a history of serious diseases such as diabetes, kidney / liver disease, heart disease or thyroid disease, adrenal disease, and other metabolic diseases. 6. Subjects who have chronic diseases and take medication on a daily basis. 7. Subjects who have a history of pollinosis or a current medical history, and who plan to use or take the drug during this research period. 8. Subjects who have been diagnosed with sleep apnea syndrome. 9. Subjects who have sensitive skin and may cause skin inflammation with adhesive plasters or adhesive tape. 10. Subjects with implantable medical devices such as cardiac pacemakers and implantable cardioverter-defibrillators. 11. Subjects who have a history or current condition of drug or alcohol dependence. 12. Subjects who are pregnant or breast-feeding, or have the will of pregnancy during this research period. 13. Women with severe symptoms such as menstrual pain and premenstrual syndrome. 14. Subjects who have food allergy. 15. Subjects who are judged to be inappropriate as research subjects by blood tests in screening tests. 16. Subjects who participate in other clinical trials, who have participated in other tests within one month of obtaining consent, or who are willing to participate. 17. Subjects who plan to travel abroad, including overseas travel, during this research period. 18. Subjects who are judged as unsuitable for the study by the investigator for the other reasons. |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nihonbashi Cardiology Clinic | ||||||
| Division name | Director | ||||||
| Zip code | 103-0001 | ||||||
| Address | Kyodo Bldg. #201, 13 - 4 Nihonbashi Kodenmacho, Chuo-ku, Tokyo | ||||||
| TEL | 03-5641-4133 | ||||||
| yiwama@well-sleep.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | KSO Corporation | ||||||
| Division name | Sales department | ||||||
| Zip code | 105-0023 | ||||||
| Address | 1-9-7 Shibaura, Minato-ku, Tokyo | ||||||
| TEL | 03-3452-7733 | ||||||
| Homepage URL | |||||||
| eigyou27@kso.co.jp | |||||||
| Sponsor | |
| Institute | KSO Corporation |
| Institute | |
| Department | |
| Funding Source | |
| Organization | TEIJIN LIMITED |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Ethical Committee of Kobuna Orthopedics Clinic |
| Address | 5-656-17 Joto-machi, Maebashi-shi, Gumma |
| Tel | 027-212-5608 |
| sagawa@mc-connect.co.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053139 |